ATE382349T1 - Antivirale verwendungen von leflunomid produkten - Google Patents

Antivirale verwendungen von leflunomid produkten

Info

Publication number
ATE382349T1
ATE382349T1 AT99912426T AT99912426T ATE382349T1 AT E382349 T1 ATE382349 T1 AT E382349T1 AT 99912426 T AT99912426 T AT 99912426T AT 99912426 T AT99912426 T AT 99912426T AT E382349 T1 ATE382349 T1 AT E382349T1
Authority
AT
Austria
Prior art keywords
leflunomide
antiviral uses
products
leflunomide products
antiviral
Prior art date
Application number
AT99912426T
Other languages
English (en)
Inventor
James Williams
Anita Chong
W Waldman
Original Assignee
Williams James W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Williams James W filed Critical Williams James W
Application granted granted Critical
Publication of ATE382349T1 publication Critical patent/ATE382349T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT99912426T 1998-03-11 1999-03-11 Antivirale verwendungen von leflunomid produkten ATE382349T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7755298P 1998-03-11 1998-03-11

Publications (1)

Publication Number Publication Date
ATE382349T1 true ATE382349T1 (de) 2008-01-15

Family

ID=22138741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912426T ATE382349T1 (de) 1998-03-11 1999-03-11 Antivirale verwendungen von leflunomid produkten

Country Status (7)

Country Link
EP (1) EP1169036B1 (de)
JP (1) JP4581137B2 (de)
AT (1) ATE382349T1 (de)
AU (1) AU3080299A (de)
DE (1) DE69937904T2 (de)
HK (1) HK1045251A1 (de)
WO (1) WO1999045908A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064755A2 (de) * 2000-02-28 2001-09-07 Bayer Aktiengesellschaft Isoxazole gegen virale erkrankungen
JP2005104852A (ja) * 2003-09-29 2005-04-21 Kyowa Hakko Kogyo Co Ltd モービリウィルス感染症の予防または治療用組成物
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
US20230097553A1 (en) * 2020-02-18 2023-03-30 East China University Of Science And Technology Anti-rna virus drug and application thereof
EP4291217B1 (de) * 2021-02-10 2026-04-01 Phytobokaz Therapeutische zusammensetzung basierend auf neurolaena blätter zur hemmung der dhodh und behandlung von rna virus infektionen
FR3119539B1 (fr) * 2021-02-10 2023-12-22 Phytobokaz Composition thérapeutique inhibitrice de la DHODH

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178596C (nl) * 1975-06-05 1986-04-16 Hoechst Ag Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
ES2124800T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
ATE174219T1 (de) * 1993-01-08 1998-12-15 Hoechst Ag Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
CN101066276A (zh) * 1994-07-01 2007-11-07 威尔斯塔特医疗公司 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体
DE19711800A1 (de) * 1997-03-21 1998-09-24 Hoechst Ag Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung

Also Published As

Publication number Publication date
WO1999045908A2 (en) 1999-09-16
JP2003523309A (ja) 2003-08-05
HK1045251A1 (zh) 2002-11-22
JP4581137B2 (ja) 2010-11-17
WO1999045908A3 (en) 2000-01-20
EP1169036B1 (de) 2008-01-02
DE69937904T2 (de) 2009-01-02
AU3080299A (en) 1999-09-27
DE69937904D1 (de) 2008-02-14
EP1169036A2 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
DK1280813T3 (da) Antivirale pyrimidin-nukleosidanaloger
TR200000782T2 (tr) Resorsinol türevleri.
WO2001060157A3 (en) Antibacterial agents and compositions
TR26910A (tr) Konsantre, sulu sivi deterjan bilesimleri.
DE69937904D1 (de) Antivirale verwendungen von leflunomid produkten
ATE362384T1 (de) Kosmetische zusammensetzungen
CA97856S (en) Bottle
DE69832880D1 (de) Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
BR0108723A (pt) Medicamentos contra doenças viróticas
DE59912720D1 (de) Sonnenschutzmittel mit mikropartikeln auf basis von wasserunlöslichem linearem polyglucan
ATE431304T1 (de) Artikelträger und zuschnitt
BR9806830A (pt) Artigo colorido rìgido
NO960849D0 (no) Difluorstaton-antivirale analoger
PT1077956E (pt) 5-aril-4-isoxazolecarbonitrilos substituidos na posicao 3 com actividade antiviral
DE69937148D1 (de) Varianten der glukoamylase
TH54346S (th) ถาด
TH16547S1 (th) ถาด
TH42456S (th) ปากกา
TH37039S (th) ลวดลายของเสื้อ
TH43551S (th) หน้าตัดชิ้นส่วนวงกบ
TH20055S1 (th) บัลลาสต์
TH67002S (th) บัลลาสต์
ID23094A (id) Bahan untuk memproduksi bahan bagunan atau barang-barang bentukan lainnya

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties